Open-label phase II study evaluating safety and efficacy of the non-steroidal farnesoid X receptor agonist PX-104 in non-alcoholic fatty liver diseaseStefan Traussnigg, Michael Trauner, Emina Halilbasic et al.|Wiener klinische Wochenschrift|2020Cited by 41
Title Page / Table of ContentsThilo Hackert, on behalf of the Dutch Pancreatitis Study Group, Alain Schoepfer et al.|Digestive Diseases|2016Cited by 0
Falk Symposium SeriesThilo Hackert, on behalf of the Dutch Pancreatitis Study Group, Alain Schoepfer et al.|Digestive Diseases|2016Cited by 0
Subject Index Vol. 34, No. 5, 2016Thilo Hackert, on behalf of the Dutch Pancreatitis Study Group, Richard M. Peek et al.|Digestive Diseases|2016Cited by 0